BioRestorative Therapies
Melville, New York, United States · Biotechnology, research · 11 employees
BioRestorative Therapies is a biotechnology company developing cell- and tissue-based therapeutic products using adult stem cell protocols. Its work focuses primarily on two key areas — disc/spine disease and metabolic disorders.
Funding history
- Series seed — $14.4M — Oct 2025
- Funding Round — $14.4M — May 2016
- Funding Round — $12.5M — Nov 2015
Recent signals
- May 29, 2026: BioRestorative Therapies Announces Employment Agreements for Key Executives
- Oct 09, 2025: Raised $14.4M in Series seed
- May 09, 2016: Raised $14.4M
- Nov 25, 2015: Raised $12.5M
See plans & pricing → Track BioRestorative Therapies’s funding, hiring, and signals — with verified contacts — on Fundz.